Inflammation-related carcinogenesis and prevention in esophageal adenocarcinoma using rat duodenoesophageal reflux models

Cancers

Volumn 3, Issue 3, 2011, Pages 3206-3224

  Fujimura, Takashi ^a   Oyama, Katsunobu ^a   Sasaki, Shozo ^a   Nishijima, Koji ^a   Miyashita, Tomoharu ^a   Ohta, Tetsuo ^a   Miwa, Koichi ^b   Hattori, Takanori ^c  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^b Houju Memorial Hospital   (Japan)

^c SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Antireflux surgery; Barrett's esophagus; Chemoprevention for esophageal adenocarcinoma; Duodenogastroesophageal reflux; Inflammation metaplasia adenocarcinoma sequence; Nonsteroidal anti inflammatory drugs; Proton pump inhibitors; Selective cyclooxygenase 2 inhibitors; Thioproline

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; ESOMEPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RABEPRAZOLE; RETINOIC ACID; ROFECOXIB; SULINDAC; TAUROURSODEOXYCHOLIC ACID; TIMONACIC;

BARRETT ESOPHAGUS; CANCER INCIDENCE; CANCER MORPHOLOGY; CANCER PREVENTION; CARCINOGENESIS; CHRONIC INFLAMMATION; DISEASE ASSOCIATION; DYSPLASIA; ESOPHAGEAL ADENOCARCINOMA; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SURGERY; HUMAN; METAPLASIA; NONHUMAN; REVIEW; SURGICAL TECHNIQUE;

EID: 80053178474     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers3033206     Document Type: Review

References (49)

1. Pera, M. Epidemiology of esophageal cancer, especially adenocarcinoma of the esophagus and esophagogastric junction. Recent Results Cancer Res. 2000, 155, 1-14.
2. Miwa, K.; Segawa, M.; Takano, Y.; Matsumoto, H.; Sahara, H.; Yagi, M.; Miyazaki, I.; Hattori, T. Induction of oesophageal and forestomach carcinomas in rats by reflux of duodenal contents. Br. J. Cancer 1994, 70, 185-189.
3. Miwa, K.; Sahara, H.; Segawa, M.; Kinami, S.; Sato, T.; Miyazaki, I.; Hattori, T. Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats. Int. J. Cancer 1996, 67, 269-274.
4. Pera, M.; Cardesa, A.; Bombi, J.A.; Ernst, H.; Pera, C.; Mohr, U. Influence of esophagojejunostomy on the induction of adenocarcinoma of the distal esophagus in Sprague-Dawley rats by subcutaneous injection of 2,6-dimethylnitrosomorpholine. Cancer Res. 1989, 49, 6803-6808.
5. Attwood, S.E.; Smyrk, T.C.; DeMeester, T.R.; Mirvish, S.S.; Stein, H.J.; Hinder, R.A. Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats. Surgery 1992, 111, 503-510.
6. Fein, M.; Peters, J.H.; Chandrasoma, P.; Ireland, A.P.; Oberg, S.; Ritter, M.P.; Bremner, C.G.; Hagen, J.A.; DeMeester, T.R. Duodenoesophageal reflux induces esophageal adenocarcinoma without exogenous carcinogen. J. Gastrointest. Surg. 1998, 2, 260-268.
7. Goldstein, S.R.; Yang, G.Y.; Curtis, S.K.; Reuhl, K.R.; Liu, B.C.; Mirvish, S.S.; Newmark, H.L.; Yang, C.S. Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. Carcinogenesis 1997, 18, 2265-2270.
8. Ireland, A.P.; Peters, J.H.; Smyrk, T.C.; DeMeester, T.R.; Clark, G.W.; Mirvish, S.S.; Adrian, T.E. Gastric juice protects against the development of esophageal adenocarcinoma in the rat. Ann. Surg. 1996, 224, 358-370.
9. Miyashita, T.; Ohta, T.; Fujimura, T.; Ninomiya, I.; Fushida, S.; Hattori, T.; Miwa, K. Duodenal juice stimulates oesophageal stem cells to induce Barrett's oesophagus and oesophageal adenocarcinoma in rats. Oncol. Rep. 2006, 15, 1469-1475.
10. Mukaisho, K.; Miwa, K.; Kumagai, H.; Bamba, M.; Sugihara, H.; Hattori, T. Gastric carcinogenesis by duodenal reflux through gut regenerative cell lineage. Dig. Dis. Sci. 2003, 48, 2153-2158.
11. Eberhard, D.; Tosh, D. Transdifferentiation and metaplasia as a paradigm for understanding development and disease Cell Mol. Life Sci. 2007, 65, 33-40.
12. Tatsuta, T.; Mukaisho, K.; Sugihara, H.; Miwa, K.; Tani, T.; Hattori, T. Expression of Cdx2 in early GRCL of Barrett's esophagus induced in rats by duodenal reflux. Dig. Dis. Sci. 2005, 50, 425-431.
13. Kazumori, H.; Ishihara, S.; Rumi, M.A.; Kadowaki, Y.; Kinoshita, Y. Bile acids directly augment caudal related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett's epithelium. Gut 2006, 55, 16-25.
14. Marchetti, M.; Caliot, E.; Pringault, E. Chronic acid exposure leads to activation of the cdx2 intestinal homeobox gene in a long-term culture of mouse esophageal keratinocytes. J. Cell Sci. 2003, 116, 1429-1436.
15. Souza, R.F.; Krishnan, K.; Spechler, S.J. Acid, bile, and CDX: The ABCs of making Barrett's metaplasia. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 295, G211-218.
16. Sato, F.; Meltzer, S.J. CpG island hypermethylation in progression of esophageal and gastric cancer. Cancer 2006, 106, 483-493.
17. Nishijima, K.; Miwa, K.; Miyashita, T.; Kinami, S.; Ninomiya, I.; Fushida, S.; Fujimura, T.; Hattori, T. Impact of the biliary diversion procedure on carcinogenesis in Barrett's esophagus surgically induced by duodenoesophageal reflux in rats. Ann. Surg. 2004, 240, 57-67.
18. Hofstetter, W.L.; Peters, J.H.; DeMeester, T.R.; Hagen, J.A.; DeMeester, S.R.; Crookes, P.F.; Tsai, P.; Banki, F.; Bremner, C.G. Long-term outcome of antireflux surgery in patients with Barrett's esophagus. Ann. Surg. 2001, 234, 532-538.
19. Csendes, A. Surgical treatment of Barrett's esophagus: 1980-2003. World J. Surg. 2004, 28, 225-231.
20. Csendes, A.; Bragheto, I.; Burdiles, P.; Smok, G.; Henriquez, A.; Parada, F. Regression of intestinal metaplasia to cardiac or fundic mucosa in patients with Barrett's esophagus submitted to vagotomy, partial gastrectomy and duodenal diversion. A prospective study of 78 patients with more than 5 years of follow up. Surgery 2006, 139, 46-53.
21. Sporn, M.B.; Dunlop, N.M.; Newton, D.L.; Smith, J.M. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed. Proc. 1976, 35, 1332-1338.
22. Abrams, J.A. Chemoprevention of esophageal adenocarcinoma. Ther. Adv. Gastroenterol. 2008, 1, 7-18.
23. Miyashita, T.; Shah, F.A.; Marti, G.P.; Wang, J.; Bonde, P.; Gibson, M.K.; Ohta, T.; Montgomery, E.A.; Duncan, M.; Harmon, J.W. Rabeprazole impedes the development of reflux-induced esophageal cancer in a surgical rat model. Dig. Dis. Sci. 2011, 56, 1309-1314.
24. Hillman, L.C.; Chiragakis, L.; Shadbolt, B.; Kaye, G.L.; Clarke, A.C. Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus. Med. J. Aust. 2004, 180, 387-391.
25. El-Serag, H.B.; Aguirre, T.V.; Davis, S.; Kuebeler, M.; Bhattacharyya, A.; Sampliner, R.E. Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus. Am. J. Gastroenterol. 2004, 99, 1877-1883.
26. García Rodríguez, L.A.; Lagergren, J.; Lindblad, M. Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: A nested case control study in the UK. Gut 2006, 55, 1538-1544.
27. Farrow, D.C.; Vaughan, T.L.; Sweeney, C.; Gammon, M.D.; Chow, W.H.; Risch, H.A.; Stanford, J.L.; Hansten, P.D.; Mayne, S.T.; Schoenberg, J.B.; Rotterdam, H.; Ahsan, H.; West, A.B.; Dubrow, R.; Fraumeni, J.F., Jr.; Blot, W.J. Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. Cancer Causes Control 2000, 11, 231-238.
28. Das, D.; Chilton, A.P.; Jankowski, J.A. Chemoprevention of oesophageal cancer and the AspECT trial. Recent Results Cancer Res. 2009, 181, 161-169.
29. Sasaki, S.; Miwa, K.; Fujimura, T.; Oba, M.; Miyashita, T.; Kinami, S. Ingestion of thioproline suppresses rat esophageal adenocarcinogenesis caused by duodenogastroesophageal reflux. Oncol. Rep. 2007, 18, 1443-1449.
30. Kumagai, H.; Mukaisho, K.; Sugihara, H.; Miwa, K.; Yamamoto, G.; Hattori, T. Thioproline inhibits development of esophageal adenocarcinoma induced by gastroduodenal reflux in rats. Carcinogenesis 2004, 25, 723-727.
31. Iijima, K.; Grant, J.; McElroy, K.; Fyfe, V.; Preston, T.; McColl, K.E. Novel mechanism of nitrosative stress from dietary nitrate with relevance to gastro-oesophageal junction cancers. Carcinogenesis 2003, 24, 1951-1960.
32. Farrow, D.C.; Vaughan, T.L.; Hansten, P.D.; Stanford, J.L.; Risch, H.A.; Gammon, M.D.; Chow, W.H.; Dubrow, R.; Ahsan, H.; Mayne, S.T.; Schoenberg, J.B.; West, A.B.; Rotterdam, H.; Fraumeni, J.F., Jr.; Blot, W.J. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol. Biomark. Prev. 1998, 7, 97-102.
33. Wilson, K.T.; Fu, S.; Ramanujam, K.S.; Meltzer, S.J. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res. 1998, 58, 2929-2934.
34. Zimmermann, K.C.; Sarbia, M.; Weber, A.A.; Borchard, F.; Gabbert, H.E.; Schror, K. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res. 1999, 59, 198-204.
35. Morris, C.D.; Armstrong, G.R.; Bigley, G.; Green, H.; Attwood, S.E. Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence. Am. J. Gastroenterol. 2001, 96, 990-996.
36. Kauer, W.K.; Peters, J.H.; DeMeester, T.R.; Ireland, A.P.; Bremner, C.G.; Hagen, J.A. Mixed reflux of gastric and duodenal juice is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Ann. Surg. 1995, 222, 525-533.
37. Stein, H.J.; Barlow, A.P.; DeMeester, T.R.; Hinder, R.A. Complications of gastroesophageal reflux disease: Role of the lower esophageal sphincter, esophageal acid acid/alkaline exposure and duodenogastric reflux. Ann. Surg. 1992, 216, 35-43.
38. Zhang, F.; Altorki, N.K.; Wu, Y.C.; Soslow, R.A.; Subbaramaiah, K.; Dannenberg, A.J. Duodenal reflux induces cyclooxygenase-2 in the esophageal mucosa of rats: evidence for involvement of bile acids. Gastroenterology 2001, 121, 1391-1399.
39. Song, S.; Guha, S.; Liu, K.; Buttar, N.S.; Bresalier, R. COX-2 induction by unconjugated bile acids involves reactive oxygen species-mediated signaling pathways in Barrett's oesophagus and oesophageal adenocarcinoma. Gut 2007, 56, 1512-1521.
40. Chen, X.; Li, N.; Wang, S.; Hong, J.; Fang, M.; Yousselfson, J.; Yang, P.; Newman, R.A.; Lubet, R.A.; Yang, C.S. Aberrant arachidonic acid metabolism in esophageal adenocarcinogenesis, and the effects of sulindac, nordihydroguaiaretic acid, and alpha-difluoromethylornithine on tumorigenesis in a rat surgical model. Carcinogenesis 2002, 23, 2095-2102.
41. Buttar, N.S.; Kenneth, K.W.; Leontovich, O.; Westcott, J.Y.; Pacifico, R.J.; Anderson, M.A.; Krishnadath, K.K.; Lutzke, L.S.; Burgart, L.J. Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. Gastroenterology 2002, 122, 1101-1112.
42. Oyama, K.; Fujimura, T.; Ninomiya, I.; Miyashita, T.; Kinami, S.; Fushida, S.; Ohta, T.; Miwa, K. A COX-2 inhibitor prevents the esophageal inflammation-metaplasia-adenocarcinoma sequence in rats. Carcinogenesis 2005, 26, 565-570.
43. Futagami, S.; Suzuki, K.; Hiratsuka, T.; Shindo, T.; Hamamoto, T.; Tatsuguchi, A.; Ueki, N.; Shinji, Y.; Kusunoki, M.; Wada, K.; Miyake, K.; Gudis, K.; Tsukui, T.; Sakamoto, C. Digestion. Celecoxib inhibits Cdx2 expression and prevents gastric cancer in Helicobacter pylori-infected Mongolian gerbils. Digestion 2006, 74, 187-198.
44. Kaur, B.S.; Khamnehei, N.; Iravani, M.; Namburu, S.S.; Lin, O.; Tradafilopoulos, G. Rofecoxib inhibits cyclooxygenase 2 expression and activity and reduce cell proliferation in Barrett's esophagus. Gastroenterology 2002, 123, 60-67.
45. Heath, E.I.; Canto, M.I.; Wu, T.T.; Piantadosi, S.; Hawk, E.; Unalp, A.; Gordon, G.; Forastiere, A.A.; CBET Research Group. Chemoprevention for Barrett's esophagus trial. Design and outcome measures. Dis. Esophagus. 2003, 16, 177-186.
46. Heath, E.I.; Canto, M.I.; Piantadosi, S.; Montgomery, E.; Weinstein, W.M.; Herman, J.G.; Dannenberg, A.J.; Yang, V.W.; Shar, A.O.; Hawk, E.; Forastiere, A.A.; Chemoprevention for Barrett's Esophagus Trial Research Group. Secondary chemoprevention of Barrett's esophagus with celecoxib: Results of a randomized trial. J. Natl. Cancer Inst. 2007, 99, 545-557.
47. Shar, A.O.; Gaudard, M.A.; Heath, E.I.; Forastiere, A.A.; Yang, V.W.; Sontag, S.J. Modeling using baseline characteristics in a small multicenter clinical trial for Barrett's esophagus. Contemp. Clin. Trials 2009, 30, 2-7.
48. Burnat, G.; Majka, J.; Konturek, P.C. Bile acids are multifunctional modulators of the Barrett's carcinogenesis. J. Physiol. Pharmacol. 2010, 61, 185-192.
49. Yamada, T.; Osawa, S.; Hamaya, Y.; Furuta, T.; Hishida, A.; Kajimura, M.; Ikuma, M. Guggulsterone suppresses bile acid-induced and constitutive caudal-related homeobox 2 expression in gut-derived adenocarcinoma cells. Anticancer Res. 2010, 30, 1953-1960.